发明授权
- 专利标题： Oral dosage forms comprising progesterone and methods of making and using the same
- 专利标题（中）： 包含孕酮的口服剂型及其制备和使用方法
-
申请号： US11441447申请日： 2006-05-26
-
公开(公告)号： US08663681B2公开(公告)日： 2014-03-04
- 发明人: Salah U. Ahmed , Charles E. Diliberti , Chandra Vattikonda , Sudhir R. Gorukanti , Sanjeev K. Gupta
- 申请人： Salah U. Ahmed , Charles E. Diliberti , Chandra Vattikonda , Sudhir R. Gorukanti , Sanjeev K. Gupta
- 申请人地址： US NJ Woodcliff Lake
- 专利权人： Teva Women's Health, Inc.
- 当前专利权人： Teva Women's Health, Inc.
- 当前专利权人地址： US NJ Woodcliff Lake
- 代理机构： Sterne, Kessler, Goldstein & Fox P.L.L.C.
- 主分类号： A61K31/56
- IPC分类号： A61K31/56
摘要：
The present invention relates to an oral pharmaceutical dosage form comprising micronized progesterone, an edible oil, a disintegrant, and a hydrophilic excipient. Particularly, the invention relates to a pharmaceutical dosage form wherein the dosage form is in a powder form and is contained in a pharmaceutically acceptable capsule. The present invention is also directed toward methods of making the dosage form, methods of using the dosage form, and kits comprising the dosage form.
公开/授权文献
信息查询
